Pricing Log in Create free account

Connect Biopharma Holdings Limited Sponsored ADR (CNTB) vs Xilio Therapeutics, Inc. (XLO)

Connect Biopharma Holdings Limited Sponsored ADR and Xilio Therapeutics, Inc. are both Biotechnology companies. Connect Biopharma Holdings Limited Sponsored ADR and Xilio Therapeutics, Inc. are of similar size ($59.4M and $57.1M). Xilio Therapeutics, Inc. has the higher net margin (−34.1% vs −2,298.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Xilio Therapeutics, Inc. leads on 12 and Connect Biopharma Holdings Limited Sponsored ADR on 2.

Valuation

Metric CNTB XLO Biotechnology median
P/E n/m n/m 8.50
P/S 19.07 2.66 9.71
P/B 2.13 2.36 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.64 0.56 9.21
Earnings yield (130.77%) (17.00%) (33.15%)
Free cash flow yield (106.62%) (36.00%) (25.50%)

Profitability

Metric CNTB XLO Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (2,346.35%) (48.94%) 0.00%
Net margin (2,298.93%) (34.06%) 0.00%
Free cash flow margin (2,018.76%) (95.59%) 0.00%
Return on equity (140.51%) (55.03%) (56.36%)
Return on assets (109.34%) (15.16%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CNTB XLO Biotechnology median
Revenue growth (TTM) — 327.25% 6.02%
EPS growth (last fiscal year) (257.14%) 72.55% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTB XLO Biotechnology median
Debt to equity 0.01 0.00 0.00
Current ratio 2.37 4.25 4.72
Net debt to EBITDA 0.77 3.40 0.96

Dividend

Metric CNTB XLO Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CNTB XLO Biotechnology median
Market cap 57.06m 59.35m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack